Chronic Conditions
-
Los Angeles Times: Soaring Insurance Deductibles and High Drug Prices Hit Sick Americans with a ‘Double Whammy’
Read more: Los Angeles Times: Soaring Insurance Deductibles and High Drug Prices Hit Sick Americans with a ‘Double Whammy’HCCI’s research on consumer-directed health plans was recently used to support the second in a series of articles by the Los Angeles Times on high-deductible health plans. From the article: “New research conducted in partnership with The Times for this project also shows that sick Americans use less healthcare when their plan requires them to pay…
-
Los Angeles Times: Health Insurance Deductibles Soar, Leaving Americans with Unaffordable Bills
Read more: Los Angeles Times: Health Insurance Deductibles Soar, Leaving Americans with Unaffordable BillsHCCI’s research on consumer-directed health plans was recently used to support the first in a series of articles by the Los Angeles Times on high-deductible health plans. From the article: “The challenges are most severe for people with the highest deductibles, according to the poll: Nearly half of those in a plan with at least…
-
Lower Health Care Spending and Use for People with Chronic Conditions in Consumer-Directed Health Plans
Read more: Lower Health Care Spending and Use for People with Chronic Conditions in Consumer-Directed Health PlansTo better understand differences in spending and use across types of health plans, we examine individuals enrolled in consumer-directed health plans (CDHPs) and individuals enrolled in non-CDHP health plans. CDHPs are a type of HDHP that typically include a health savings account (HSA) or a health reimbursement arrangement (HRA). We analyzed a sample of over…
-
The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly Insulin
Read more: The New York Times: Express Scripts Offers Diabetes Patients a $25 Cap for Monthly InsulinHCCI’s research on rising insulin list prices was recently cited by The New York Times in its reporting on Express Scripts’ new plan to offer a $25 cap for month insulin. From the article: “Consumers whose drug benefits are managed by Express Scripts could see their out-of-pocket costs for insulin limited to $25 a month…
-
HCCI Insulin Report Receives Extensive Media Coverage
Tags: CBS, Chronic Conditions, CNN, Diabetes, Drug Spending, HCCI News, Insulin, NBC, Prices, The New York TimesRead more: HCCI Insulin Report Receives Extensive Media CoverageHCCI’s recent report on trends in rising insulin prices received additional media coverage in the last week in outlets including NBC, CBS, CNN, The New York Times, The Hill, U.S. News & World Report, and USA Today. From CNN: “Congress and the Trump administration continue to push for a drug pricing plan and were given more…
-
Reuters: U.S. Insulin Costs Per Patient Nearly Doubled From 2012 to 2016: Study
Read more: Reuters: U.S. Insulin Costs Per Patient Nearly Doubled From 2012 to 2016: StudyHCCI’s latest research on rising insulin prices was recently featured in Reuters. HCCI’s report detailed both use and price trends of insulin used by those with type 1 diabetes from 2012 to 2016. Per Reuters article: “A person with type 1 diabetes incurred annual insulin costs of $5,705, on average, in 2016. The average cost was…
-
Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin Prices
Read more: Spending on Individuals with Type 1 Diabetes and the Role of Rapidly Increasing Insulin PricesWe used health care claims data to investigate trends in total health care spending on individuals with type 1 diabetes between 2012 and 2016. We found a rapid increase in total health care spending, driven primarily by gross spending on insulin that doubled over the period. During that time insulin use rose only modestly. While…
-
The Rising Cost of Specialty Drugs Drove Spending Increases for People with Multiple Sclerosis
Read more: The Rising Cost of Specialty Drugs Drove Spending Increases for People with Multiple SclerosisThis issue brief investigates how the cost of prescription drugs affects the total cost of care for people with multiple sclerosis (MS). It decomposes total health care spending by category, specifically separating out spending on specialty drugs used to treat MS, called Disease Modifying Therapies (DMTs). The issue brief subsequently examines whether changes in spending…
-
Under Pressure – Adults with Hypertension are Spending Increasingly More on Health Care
Read more: Under Pressure – Adults with Hypertension are Spending Increasingly More on Health CareThis issue brief compares trends in health care spending from 2012 to 2016 for adults with employer-sponsored insurance who were diagnosed with hypertension to those not diagnosed with hypertension. It also considers how changes in prescription drug spending compare to changes in prescription drug use for adults with a hypertension diagnosis.
-
Times Free Press: Cost of care growing for adults with hypertension
Read more: Times Free Press: Cost of care growing for adults with hypertensionBy: Elizabeth Fite Hypertension, or high blood pressure, affects the health and wallets of more than 75 million U.S. adults, and the cost of managing this condition is growing, according to a new study from the Health Care Cost Institute. The study released Tuesday analyzed data from employer-sponsored health insurance claims of adults between the ages…